Home FOR AUTHORS Neoplasma 2019 Neoplasma Vol.66, No.3, p.336-342, 2019

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.66, No.3, p.336-342, 2019

Title: FBLN3 inhibits the invasion and metastasis of colorectal cancer through the AKT/mTOR pathway
Author: H. Y. Mao, S. P. Liu, G. M. Kong, Y. Xu, Y. C. Xu, G. Z. Sun, Z. Wang, F. Han, J. D. Tong, P. Bo

Abstract: Fibulin-3 (FBLN3) levels vary among different types of cancers. We found that fibulin-3 was downregulated in colorectal cancer (CRC) cells, particularly in the SW480 cell line. However, transfecting SW480 cells with a lentivirus overexpressing fibulin-3 RNA inhibited proliferation, induced G1/S arrest, and promoted apoptosis. Fibulin-3 overexpression also suppressed CRC invasion and metastasis. These effects were regulated through the AKT/mTOR signaling pathway.

Keywords: fibulin-3, invasion, metastasis, colorectal cancer, AKT/mTOR pathway
Published online: 28-May-2019
Year: 2019, Volume: 66, Issue: 3 Page From: 336, Page To: 342
doi:10.4149/neo_2018_180703N441


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.